SİNEM ÖZLEM ENGİNLER, TUĞBA SEVAL FATMA TOYDEMİR KARABULUT, ATİLA ATEŞ, IRAZ AKIŞ AKAD, Haydar ARMAĞAN, Kemal ÖZTABAK, İSMAİL KIRŞAN, MEHMET CAN GÜNDÜZ, İbrahim FIRAT

Assessment of prolactin, steroid hormone levels in tissue homogenate, serum and receptor distributions in canine mammary tumours

Bu çalışmanın amacı östron sülfat (SO4E1), progesteron (P4), östradiol 17-beta (E2), testosteron (T) ve prolaktin (PRL) seviyeleri değişikliklerinin serumda ve doku homojenatında, androjen (AR), östrojen alfa (ERα), progesteron (PR) ve prolaktin (PRL-R) reseptör dağılım değişikliklerinin köpeklerde meme tümörlerinde saptanmasıdır. Değişik ırk ve yaşta meme lezyonlu otuz köpek (çalışma grubu) ve 10 sağlıklı köpek (herhangi bir meme lezyonu olmayan=kontrol grubu) çalışmada kullanıldı. Çalışmaya katılan tüm köpekler anöstrustaydı. Çalışma grubu köpeklerin meme lezyonları cerrahi olarak uzaklaştırıldı ve 10 normal meme dokusu örneği kontrol grubu köpeklerden cerrahi biyopsi ile toplandı. Elli-yedi meme dokusu örneği toplandı, histopatoloji/immunohistokimya ve doku homojenatında hormon değişikliklerinin saptanması için iki parçaya ayrıldı. Bunun dışında, tüm köpeklerden ameliyat öncesi kan örnekleri toplandı. Serum örnekleri için student t-test, one way ANOVA ve tukey testi de doku homojenatında istatistiki analiz için kullanıldı. Bu çalışmanın sonuçlarına göre, serumda PRL seviyeleri çalışma grubunda önemli olarak (P

Meme tümörlü köpeklerde serumda, doku homojenatında prolaktin ve steroid hormon seviyeleri ile reseptör dağılımlarının belirlenmesi

The aim of the present study is to determine variations of estrone sulphate (SO4E1), progesterone (P4), 17-beta estradiol (E2), testosterone (T) and prolactin (PRL) levels in serum, mammary tissue homogenates as well as variations in the distribution of androgen (AR), estrogen alpha (ERα), progesterone (PR) and prolactin (PRL-R) receptors in mammary tumours of dogs. Thirty bitches from different breeds and ages with mammary lesions (experiment group) and 10 healthy bitches (free of any mammary lesions=control group) were used in this study. All the dogs included to the study were in anoestrus. Mammary lesions of experiment group were surgically removed and 10 normal mammary tissue samples were collected by surgical biopsy from control group dogs. Fifty-seven mammary tissue samples were obtained and were divided into two fragments for histopathology/ immunohistochemistry and for hormone determinations in tissue homogenate. Besides, blood samples were collected from all dogs before the surgeries to detect hormonal variations. Student t-test was used for serum samples, one way ANOVA and tukey test were used in tissue homogenate for statistical analysis. According to current study results; PRL levels in serum were found significantly higher (P<0.01) in the experiment group compared to the control group. In tissue homogenate samples, T levels were found to be significantly (P<0.01) higher in malignant mammary tissue samples. PR was intensely expressed in 23, PRL-R was expressed in 13, ERα was expressed in 9 and AR was expressed in 6 cases of canine malignant mammary tumours (CMTs). In conclusion, PRL levels in serum, T in tissue can act on the formation of canine mammary tumours which may have different features of developments in different mammary glands of the same dog and with the predominance of PR expression in CMT.

PDF

___

1. Rutteman GR, Misdorp W: Hormonal background of canine and feline mammary tumours. J Reprod Fertil Suppl, 47, 483-487, 1993.
2. Sorenmo KU, Shofer FS, Goldschmidt MH: Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med, 14, 266-270, 2000.
3. Hellmen E: Complex mammary tumours in the female dog: A review. J Dairy Res, 72, 90-97, 2005.
4. Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I, Poli A: Comparison of steroid receptor expression in normal, dyslastic, and neoplastic canine and feline mammary tissues. Res Vet Sci, 79, 225- 232, 2005.
5. Queiroga FL, Perez-Alenza MD, Silvan G, Pena L, Lopes C, Illera JC: Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol, 94, 181-187, 2005.
6. Rivera P, Melin M, Biagi T, Fall T, Haggström J, Lindblad-Toh K, von Euler H: Mammary tumor deveopment in dogs is associated with BRCA1 and BRCA2. Cancer Res, 69 (22): 8770-8774, 2009.
7. Hsu WL, Huang YH, Chang TJ, Wong ML, Chang S-C: Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. Vet J, 184 (3): 351-356, 2010.
8. Sanchez-Archidona AR, Jimenez MA, Perez-Alenza D, Silvan G, Illera JC, Pena L, Dunner S: Steroid pathway and oestrone sulphate production in canine inflammatory mammary carcinoma. J Steroid Biochem Mol Biol, 104, 93-99, 2007.
9. Pena L, Silvan G, Perez-Alenza MD, Nieto A, Illera JC: Steroid hormone profile of canine inflammatory mammary carcinoma: A preliminary study. J Steroid Biochem Mol Biol, 84, 211-216, 2003.
10. Gatter KC: Diagnostic immunohistochemistry: Achievements and challenges. J Pathol, 159, 183-190, 1989.
11. Folpe AL: Practical applications of immunohistochemistry in the diagnosis of soft tissue neoplasms. Surg Oncol, 8, 197-203, 1999.
12. Folpe AL, Gown AM: Immunohistochemistry for analysis of soft tissue tumors. In, Weiss SW, Goldblum JR, Sharon WW (Eds): Enzinger and Weiss’s Soft Tissue Tumors. 4th ed., 199-245, Mosby, St Louis, USA, 2001.
13. Misdorp W, Else R, Hellmen W, Lipscomb TP: Histological Classification of Mammary Tumors of the Dog and Cat. Second series, Vol. VII. 11-29, Published by the Armed Forces Institute of Pathology, Washington, DC, 1999.
14. Illera JC, Perez-Alenza MD, Nieto A, Jimenez MA, Silvan G, Dunner S, Pena L: Steroids and receptors in canine mammary cancer. Steroids, 71, 541-548, 2006.
15. Liao DJ, Dickson RB: Roles of androgens in the development, growth and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol, 80, 175-189, 2002.
16. Maggiolini M, Donze O, Jeannin E, Ando S, Picard D: Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor α. Cancer Res, 59, 4864-4869, 1999.
17. Ginsburg E, Vonderhaar BK: Prolactin synthesis and secretion by human breast cancer cells. Cancer Res, 55 (12): 251-255, 1995.
18. Shaw-Bruha CM, Pirrucello SJ, Shull JD: Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing. Breast Cancer Res Treat, 44, 243-253, 1997.
19. Michel E, Feldmann SK, Kowalewski MP, Bley CR, Boos A, Guscetti F, Reichler IM: Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas. BMC Vet Res, 8 (72): 2-8, 2012.
20. Toniti W, Buranasinsup S, Kongcharoen A, Charoonrut P, Puchadapirom P, Kasorndorkbua C: Immunohistochemical determination of estrogen and progesterone receptors in canine mammary tumors. Asian Pac J Cancer Prev, 10 (5): 907-911, 2009.
21. Pena L, Silvan G, Perez-Alenza MD, Rodriguez-Bertos A, Nieto A: Canine inflammatory mammary carcinoma: Histopathology, immuno- histochemistry and clinical implications of 21 cases. Breast Cancer Res Treat, 78, 141-148, 2003.
22. Golshahi H, Tavasoly A, Rezaie A, Farhadi M: Immunohisto- chemical and histopathological findings of chondrosarcoma in mammary gland of a dog: A case report. Kafkas Univ Vet Fak Derg, 19 (6): 1053-1056, 2013. DOI: 10.9775/kvfd.2013.9215